New stock news | Hansi Aitai Hong Kong stock IPO prospectus failed

According to the financial news app "Intelligence Finance", the Hong Kong stock prospectus submitted by Hansei Aitai Biopharmaceutical Technology (Wuhan) Co., Ltd. (referred to as "Hansei Aitai") on November 24, 2024, expired on May 24, 2025, six months after submission. Industrial and Commercial Bank International was the exclusive sponsor of the prospectus at the time of submission.